β-cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome

Journal of Endocrinology

Volumn 219, Issue 3, 2013, Pages 231-241

  Fransson, Liselotte ^a   Franzén, Stephanie ^b   Rosengren, Victoria ^a   Wolbert, Petra ^a   Sjöholm, Åke ^a,c   Ortsäter, Henrik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Diabetes; Glucocorticoid; Insulin secretion; Islet cells; Obesity

Indexed keywords

CORTICOSTERONE; DRINKING WATER; INSULIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; DYSLIPIDEMIA; FATTY LIVER; FOOD INTAKE; GLUCOSE TOLERANCE TEST; HUMORAL IMMUNITY; HYPERTENSION; INSULIN SENSITIVITY; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; WEIGHT GAIN;

DIABETES; GLUCOCORTICOID; INSULIN SECRETION; ISLET CELLS; OBESITY;

ADIPOSITY; ADMINISTRATION, ORAL; ALLOSTASIS; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; ENERGY INTAKE; GLUCOCORTICOIDS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; WEIGHT GAIN;

EID: 84890160793     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0189     Document Type: Article

References (51)

1. Ahren J, Ahren B & Wierup N 2010 Increased b-cell volume in mice fed a high-fat diet: a dynamic study over 12 months. Islets 2 353-356.
2. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A & Mikhailidis DP 2009 The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. Journal of Clinical Endocrinology and Metabolism 94 2692-2701.
3. Baid S & Nieman LK 2004 Glucocorticoid excess and hypertension. Current Hypertension Reports 6 493-499.
4. Barel M, Perez OA, Giozzet VA, Rafacho A, Bosqueiro JR & do Amaral SL 2010 Exercise training prevents hyperinsulinemia, muscular glycogen loss and muscle atrophy induced by dexamethasone treatment. European Journal of Applied Physiology 108 999-1007.
5. Bock T, Pakkenberg B & Buschard K 2003 Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52 1716-1722.
6. Christ-Crain M, Kola B, Lolli F, Fekete C, Seboek D, Wittmann G, Feltrin D, Igreja SC, Ajodha S, Harvey-White J et al. 2008 AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome. FASEB Journal 22 1672-1683.
7. Duclos M, Marquez Pereira P, Barat P, Gatta B & Roger P 2005 Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obesity Research 13 1157-1166.
8. Eizirik DL & Cnop M 2010 ER stress in pancreatic b cells: the thin red line between adaptation and failure. Science Signaling 3 pe7.
9. Ellgaard L & Helenius A 2003 Quality control in the endoplasmic reticulum. Nature Reviews. Molecular Cell Biology 4 181-191.
10. Feek CM, Marante DJ & Edwards CR 1983 The hypothalamic-pituitary-adrenal axis. Clinics in Endocrinology and Metabolism 12 597-618.
11. Gelfand RA, Matthews DE, Bier DM & Sherwin RS 1984 Role of counterregulatory hormones in the catabolic response to stress. Journal of Clinical Investigation 74 2238-2248.
12. Gepts W, Christophe J & Mayer J 1960 Pancreatic islets in mice with the obese-hyperglycemic syndrome: lack of effect of carbutamide. Diabetes 9 63-69.
13. Grankvist N, Amable L, Honkanen RE, Sjoholm A & Ortsater H 2012 Serine/threonine protein phosphatase 5 regulates glucose homeostasis in vivo and apoptosis signalling in mouse pancreatic islets and clonal MIN6 cells. Diabetologia 55 2005-2015.
14. Gulliford MC, Charlton J & Latinovic R 2006 Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care 29 2728-2729.
15. Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, van Meeteren LA, Samen E, Lu L, Vanwildemeersch M et al. 2010 Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464 917-921.
16. Hagberg CE, Mehlem A, Falkevall A, Muhl L, Fam BC, Ortsater H, Scotney P, Nyqvist D, Samen E, Lu L et al. 2012 Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature 490 426-430.
17. Karatsoreos IN, Bhagat SM, Bowles NP, Weil ZM, Pfaff DW & McEwen BS 2010 Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology 151 2117-2127.
18. Kassi E, Pervanidou P, Kaltsas G & Chrousos G 2011 Metabolic syndrome: definitions and controversies. BMC Medicine 9 48.
19. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2KDDCT method. Methods 25 402-408.
20. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 265-275.
21. Marin P, Darin N, Amemiya T, Andersson B, Jern S & Bjorntorp P 1992 Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41 882-886.
22. McDonough AK, Curtis JR & Saag KG 2008 The epidemiology of glucocorticoid-associated adverse events. Current Opinion in Rheumatology 20 131-137.
23. Mendizabal Y, Llorens S & Nava E 2013 Hypertension in metabolic syndrome: vascular pathophysiology. International Journal of Hypertension 2013 230868.
24. Misra A, Jaiswal A, Shakti D, Wasir J, Vikram NK, Pandey RM, Kondal D & Bhushan B 2008 Novel phenotypic markers and screening score for the metabolic syndrome in adult Asian Indians. Diabetes Research and Clinical Practice 79 e1-e5.
25. Muhtz C, Zyriax BC, Klahn T, Windler E & Otte C 2009 Depressive symptoms and metabolic risk: effects of cortisol and gender. Psychoneuroendocrinology 34 1004-1011.
26. Nikolopoulou A & Kadoglou NP 2012 Obesity and metabolic syndrome as related to cardiovascular disease. Expert Review of Cardiovascular Therapy 10 933-939.
27. Novelli M, De Tata V, Bombara M, Lorenzini A, Masini M, Pollera M, Bergamini E & Masiello P 1999 Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated ageing rats. Journal of Endocrinology 162 425-432.
28. Ortsater H & Sjoholm A 2007 A busy cell -endoplasmic reticulum stress in the pancreatic b-cell. Molecular and Cellular Endocrinology 277 1-5.
29. Pasquali R, Ambrosi B, Armanini D, Cavagnini F, Uberti ED, Del Rio G, de Pergola G,Maccario M, Mantero F,MarugoMet al. 2002 Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. Journal of Clinical Endocrinology and Metabolism 87 166-175.
30. Pasquali R, Vicennati V, Cacciari M & Pagotto U 2006 The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Annals of the New York Academy of Sciences 1083 111-128.
31. Patterson ZR, Khazall R, Mackay H, Anisman H & Abizaid A 2013 Central ghrelin signaling mediates the metabolic response of C57BL/6 male mice to chronic social defeat stress. Endocrinology 154 1080-1091.
32. Quan ZY & Walser M 1992 Effects of corticosterone administration on nitrogen excretion and nitrogen balance in adrenalectomized rats. American Journal of Clinical Nutrition 55 695-700.
33. Rafacho A, Giozzet VA, Boschero AC & Bosqueiro JR 2008 Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance. Pancreas 36 284-293.
34. Rafacho A, Cestari TM, Taboga SR, Boschero AC & Bosqueiro JR 2009 High doses of dexamethasone induce increased b-cell proliferation in pancreatic rat islets. American Journal of Physiology. Endocrinology and Metabolism 296 E681-E689.
35. Rafacho A, Marroqui L, Taboga SR, Abrantes JL, Silveira LR, Boschero AC, Carneiro EM, Bosqueiro JR, Nadal A & Quesada I 2010a Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets. Endocrinology 151 85-95.
36. Rafacho A, Quallio S, Ribeiro DL, Taboga SR, Paula FM, Boschero AC & Bosqueiro JR 2010b The adaptive compensations in endocrine pancreas from glucocorticoid-treated rats are reversible after the interruption of treatment. Acta Physiologica 200 223-235.
37. Rafacho A, Abrantes JL, Ribeiro DL, Paula FM, Pinto ME, Boschero AC & Bosqueiro JR 2011 Morphofunctional alterations in endocrine pancreas of short-and long-term dexamethasone-treated rats. Hormone and Metabolic Research 43 275-281.
38. Raul Ariza-Andraca C, Barile-Fabris LA, Frati-Munari AC & Baltazar-Montufar P 1998 Risk factors for steroid diabetes in rheumatic patients. Archives of Medical Research 29 259-262.
39. Reynolds RM, Walker BR, Syddall HE, Whorwood CB, Wood PJ & Phillips DI 2001 Elevated plasma cortisol in glucose-intolerant men: differences in responses to glucose and habituation to venepuncture. Journal of Clinical Endocrinology and Metabolism 86 1149-1153.
40. Rosmond R, Dallman MF & Bjorntorp P 1998 Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. Journal of Clinical Endocrinology and Metabolism 83 1853-1859.
41. Sachdeva MM & Stoffers DA 2009 Minireview: meeting the demand for insulin: molecular mechanisms of adaptive postnatal b-cell mass expansion. Molecular Endocrinology 23 747-758.
42. Sargsyan E, Ortsater H, Thorn K & Bergsten P 2008 Diazoxide-induced b-cell rest reduces endoplasmic reticulum stress in lipotoxic b-cells. Journal of Endocrinology 199 41-50.
43. Schacke H, Docke WD & Asadullah K 2002 Mechanisms involved in the side effects of glucocorticoids. Pharmacology & Therapeutics 96 23-43.
44. Sen Y, Aygun D, Yilmaz E & Ayar A 2008 Children and adolescents with obesity and the metabolic syndrome have high circulating cortisol levels. Neuroendocrinology Letters 29 141-145.
45. Shepherd PR 2005 Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiologica Scandinavica 183 3-12.
46. Shpilberg Y, Beaudry JL, D'Souza A, Campbell JE, Peckett A & Riddell MC 2012 A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding. Disease Models & Mechanisms 5 671-680.
47. Tchernof A & Despres JP 2013 Pathophysiology of human visceral obesity: an update. Physiological Reviews 93 359-404.
48. Vegiopoulos A & Herzig S 2007 Glucocorticoids,metabolism andmetabolic diseases. Molecular and Cellular Endocrinology 275 43-61.
49. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV & Penninx BW 2007 Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32 151-159.
50. Wajchenberg BL, Prestes Cesar F, Okada H, Torres de Toledo e Souza I, Lerario AC, Borghi VC, Malerbi DA, Giurna Filho A, Liberman B & Gianella D 1984 Glucocorticoids, glucose metabolism and hypothalamic-pituitary-adrenal axis. Advances in Experimental Medicine and Biology 171 25-44.
51. WeigensbergMJ, Toledo-Corral CM& Goran MI 2008 Association between the metabolic syndrome and serum cortisol in overweight Latino youth. Journal of Clinical Endocrinology and Metabolism 93 1372-1378.